İSLAMOĞLU, F. 2024. Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS). Prospects in Pharmaceutical Sciences , vol.22, no.4 , 168-187.

İSLAMOĞLU, F., (2024). Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS). Prospects in Pharmaceutical Sciences , vol.22, no.4, 168-187.

İSLAMOĞLU, FATİH. "Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)," Prospects in Pharmaceutical Sciences , vol.22, no.4, 168-187, 2024

İSLAMOĞLU, FATİH. "Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)." Prospects in Pharmaceutical Sciences , vol.22, no.4, pp.168-187, 2024

İSLAMOĞLU, F. (2024) . "Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)." Prospects in Pharmaceutical Sciences , vol.22, no.4, pp.168-187.

@article{article, author={FATİH İSLAMOĞLU}, title={Molecular docking, bioactivity, adme, toxicity risks, and quantum mechanical parameters of some 1,2-dihydroquinoline derivatives were calculated theoretically for investigation of its use as a pharmaceutical active ingredient in the treatment of multiple sclerosis (MS)}, journal={Prospects in Pharmaceutical Sciences}, year=2024, pages={168-187} }